title: A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats.
abstract: This study investigated if quinacrine can induce a tumorigenic response in rats when administered in a manner similar to the intended human use for female non-surgical sterilization. Young sexually mature female rats received two doses of quinacrine (or 1% methylcellulose control) into each uterine horn approximately 21 days apart, and were observed for 23 months after the second dose administration. Dose levels were 0/0, 0/0, 10/10, 70/70, and 70/250-350 mg/kg (first dose/second dose), which represent local doses in the uterus at approximate multiples of 1x, 8x and 40x the human dose (mg quinacrine/g uterine weight) used for female non-surgical sterilization. Rats were observed for viability, clinical signs of toxicity, and changes in body weight and food consumption. At necropsy, selected organs were weighed, macroscopic observations were recorded, and tissues were collected, fixed, processed, and examined for microscopic pathologic findings. Acute quinacrine toxicity was evident during the dosing period but did not affect long-term survival. Non-neoplastic findings were more common in treated animals than controls, providing evidence of the appropriateness of the bioassay. The incidence of uncommon tumors of the reproductive tract was similar to controls at doses of 10/10mg/kg but increased with dose level and was significantly greater than controls at >or=70/70 mg/kg. We conclude that two doses of quinacrine administered approximately 21 days apart into the uterus of young sexually mature rats at a local dose approximately 8 times the human dose used for non-surgical female sterilization increased the lifetime risk of tumor development in the reproductive tract.
authors.affiliation: Family Health International, P.O. Box 13950, Research Triangle Park, NC 27709, USA. acancel@fhi.org
authors.forename: Aida M
authors.initials: AM
authors.lastname: Cancel
authors.forename: John E
authors.initials: JE
authors.lastname: Dillberger
authors.forename: Catherine M
authors.initials: CM
authors.lastname: Kelly
authors.forename: Henry F
authors.initials: HF
authors.lastname: Bolte
authors.forename: Dianne M
authors.initials: DM
authors.lastname: Creasy
authors.forename: David C
authors.initials: DC
authors.lastname: Sokal
mesh_terms: D000367:Age Factors; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005187:Fallopian Tubes / Q000187:drug effects / Q000473:pathology; D005260:Female; D008136:Longevity; D011796:Quinacrine / Q000008:administration & dosage* / Q000633:toxicity*; D051381:Rats; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014599:Uterus / Q000187:drug effects* / Q000473:pathology
chemical_list: D011796:Quinacrine